Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Earnings release
confidence 95%
filed 2026-08-13
Item 2.02
Enhanced Group Inc. issued a press release on August 13, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing revenue of $17.7 million, net loss of $61.9 million, and adjusted EBITDA loss of $42.7 million. The press release is furnished as Exhibit 99.1 and constitutes a standard quarterly earnings disclosure under Item 2.02, which is material to investors assessing the company's financial performance and operational progress in its first reported public quarter.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure explicitly states "Merlin, Inc. (the 'Company') issued a press release announcing its financial results for the second quarter ended June 30, 2026," with the press release furnished as Exhibit 99.1. The exhibit contains detailed financial results including revenue ($2.2M), net loss ($58.4M), and cash position ($183.9M), along with business highlights and forward-looking guidance. This is a material disclosure affecting investor assessment of the registrant's financial performance and operational progress.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-13
EX-99.1
This is a press release disclosing Nomad Foods' second quarter and first six months 2026 financial results, including revenue (€724m for Q2, down 3.1%), Adjusted EBITDA (€124m for Q2, down 4.3%), and Adjusted EPS (€0.39 for Q2, down 2.5%). The document includes condensed consolidated interim financial statements, cash flow data, and updated full-year guidance. This is a discrete earnings announcement, not a periodic financial report filing.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
PEDEVCO issued a press release on August 13, 2026 announcing financial results for Q2 2026 and the first half of 2026, disclosing revenue of $46.1 million (up 561% YoY), net income of $17.5 million (vs. a loss in Q2 2025), and Adjusted EBITDA of $18.7 million. The filing explicitly states the press release is furnished as Exhibit 99.1 and is incorporated by reference, which is the standard format for earnings releases under Item 2.02. The results show material improvements in production, profitability, and balance sheet metrics following the October 2025 Juniper Merger.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
TSS, Inc. issued a press release on August 13, 2026, reporting financial results for the three and six months ended June 30, 2026. The Item 2.02 disclosure explicitly states the company "issued a press release reporting certain financial results" and furnishes the press release as Exhibit 99.1. The exhibit contains detailed quarterly and year-to-date financial statements, revenue breakdowns by segment, gross profit, net income, diluted EPS, and Adjusted EBITDA metrics—all hallmarks of an earnings release. The company also announced a conference call to discuss results, further confirming this is a standard quarterly earnings disclosure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
Item 7.01
The filing discloses consolidated operating and financial results for Q2 2026 ending June 30, 2026, presented in a press release format with detailed financial statements (income statement and balance sheet). The disclosure includes revenue of $10,732,335 (up 13.25% YoY), net income of $3,651,596 (up 31.95% YoY), and EPS of $0.23 (up 15% YoY), along with operational metrics. This is a standard quarterly earnings release furnished under Item 7.01 (Regulation FD Disclosure).
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
YETI issued a press release on August 13, 2026 announcing its second quarter 2026 financial results, including net sales of $483.9 million (up 9%), net income per diluted share of $0.94 (up 54%), and an updated full-year 2026 EPS outlook raised to $2.94–$3.00. This is a standard quarterly earnings release disclosure under Item 2.02, material to investors assessing the company's financial performance and trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
Item 2.02
The filing discloses quarterly financial results for the period ended June 30, 2026, including a press release issued on August 13, 2026 (Exhibit 99.1) that reports Q1 fiscal 2027 results with consolidated balance sheets and statements of operations. The Item 2.02 explicitly incorporates Item 7.01 (Regulation FD Disclosure) which contains the earnings announcement, making this a standard earnings release disclosure with financial statements and operational highlights.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
Item 2.02
The filing discloses quarterly financial results for Q2 2026 (ended June 30, 2026) via a press release issued on August 13, 2026. The Item 2.02 section explicitly states "the Company issued a press release announcing its financial results for the quarter ended June 30, 2026," and the exhibit includes condensed consolidated balance sheets, statements of operations, and cash flows. This is a standard earnings release disclosure material to investors assessing the registrant's financial condition and operational performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
Item 2.02
The filing discloses T Stamp Inc.'s financial results for the six months ended June 30, 2026, including net recognized revenue of $1.66 million (22% increase), operating expenses of $6.32 million, and net loss of $4.93 million. The press release attached as Exhibit 99.1 presents these results alongside operational and strategic updates, which is the standard format for an earnings release under Item 2.02.
View raw filing on EDGAR →
6-K
Earnings release
confidence 92%
filed 2026-08-13
EX-99.1
This is a press release disclosing Alithya's first quarter fiscal 2027 financial results (ended June 30, 2026), including revenues of $105.1 million (down 15.4%), net loss of $2.4 million, and adjusted EBITDA of $5.4 million (down 53.4%). The document explicitly states "Alithya reports first quarter Fiscal 2027 results" and provides comprehensive quarterly financial highlights and analysis. While the release also mentions a strategic review process, the primary disclosure is the quarterly earnings announcement, which is material to investors assessing the company's financial performance and trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
Item 2.02
Charlotte's Web issued an earnings release on August 13, 2026, announcing financial results for the three and six months ended June 30, 2026. The disclosure includes detailed quarterly revenue ($10.9M vs. $12.8M YoY), gross profit, operating loss, net loss, and balance sheet metrics. This is a standard earnings release filed under Item 2.02 with the press release furnished as Exhibit 99.1, which is the typical format for quarterly financial results disclosure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
HawkEye 360 issued a press release on August 13, 2026, announcing Q2 2026 financial results with revenue of $49.8 million (up 87% YoY), net loss of $15.3 million, backlog of $292.2 million, and full-year 2026 guidance of $215–$220 million.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
Item 2.02
This is a clear earnings release for Q2 2026 filed under Item 2.02. The press release discloses quarterly financial results including revenues of $2.3 million (down 68.5% YoY), net loss of $8.7 million per share, and adjusted EBITDA of negative $3 million. The filing includes consolidated statements of operations and balance sheet data, making this a standard quarterly earnings announcement material to investors assessing the company's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
Item 2.02
Cabaletta Bio announced its financial results for the second quarter ended June 30, 2026, via press release furnished as Exhibit 99.1. The disclosure includes quarterly R&D expenses ($44.4M vs. $37.6M YoY), G&A expenses ($7.6M vs. $8.3M YoY), and cash position ($225.1M as of June 30, 2026), along with operational highlights and clinical milestones. This is a standard quarterly earnings release disclosing results of operations and financial condition under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
Solo Brands issued a press release on August 13, 2026, disclosing financial results for the quarterly period ended June 30, 2026 (Q2 2026). The disclosure includes consolidated and segment-level results with net sales of $88.5 million, net loss of $4.4 million, adjusted EBITDA of $13.5 million, and reaffirmed full-year 2026 guidance. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, which is material to investors assessing the registrant's financial performance and operational trends.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
Item 8.01
The filing discloses quarterly financial results for the period ended June 30, 2026, including net investment income per share of $0.61, earnings per share of $0.41, net asset value per share of $25.96, and distributions declared of $0.60 per share. The press release attached as Exhibit 99.1 is a standard earnings announcement for a BDC reporting its quarterly financial performance and investment activity, which is material to investors assessing the fund's performance and distribution capacity.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
Item 2.02
Pelthos Therapeutics disclosed second quarter 2026 financial results via press release, reporting net product revenue of $15.4 million (45% QoQ growth) and a net loss of $(23.4) million, along with operational highlights including Zelsuvmi unit dispensing growth.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
McGraw Hill issued a press release on August 13, 2026, announcing financial results for the fiscal first quarter ended June 30, 2026, including total revenue of $549.9 million, net income of $57.9 million, Adjusted EBITDA of $207.0 million, segment performance, and fiscal year 2027 guidance.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-13
The 6-K body explicitly states that on August 13, 2026, Bending Spoons issued a press release announcing its results for Q2 2026, with the press release furnished as Exhibit 99.1 and quarterly unaudited financial statements as Exhibit 99.2. This is a discrete earnings announcement event, not a periodic financial report filing itself. Quarterly earnings releases are material to investors and constitute a standard earnings_release classification.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
Item 2.02
Inhibrx issued a press release on August 13, 2026 announcing financial results for the three and six months ended June 30, 2026, including revenue, operating expenses, net loss, cash position, and balance sheet data. This is a standard quarterly earnings disclosure furnished under Item 2.02, with the press release attached as Exhibit 99.1. The disclosure is material as it reports significant financial metrics including a net loss of $36.7 million for Q2 2026 and changes in the company's cash and debt position.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-13
Item 2.02
Newsmax Inc. issued a press release announcing Q2 2026 financial results, reporting record quarterly revenues of $54.1 million (16.5% year-over-year growth), net income of $2.9 million (the company's first profitable quarter as a public company), and adjusted EBITDA of $5.7 million, along with detailed segment breakdowns and forward guidance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
Figure Technology Solutions issued a press release on August 13, 2026 announcing financial results for the three and six months ended June 30, 2026, disclosing strong quarterly performance including 132% year-over-year volume growth, net revenue of $226 million (113% YoY increase), and net income of $87 million (192% YoY increase). This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's financial performance and operational trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
Item 2.02
Fermi Inc. issued its earnings release on August 13, 2026, announcing financial results for the second quarter ended June 30, 2026. The disclosure includes condensed consolidated balance sheets and statements of operations, along with detailed operational and financial highlights. This is a standard quarterly earnings release filed under Item 2.02 (Results of Operations and Financial Condition), furnished as Exhibit 99.1, and is material to investors assessing the company's financial condition and operational progress.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
Brinker International issued a press release on August 12, 2026 announcing fourth quarter and full year fiscal 2026 financial results, including company sales of $1,521.2 million (Q4) and $5,750.9 million (FY), net income per diluted share of $2.99 (Q4) and $10.87 (FY), comparable restaurant sales growth of 8.1% for the year, and provided fiscal 2027 guidance with estimated total revenues of $6.15–$6.27 billion.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-12
Item 2.02
STAAR Surgical published a press release on August 12, 2026 reporting second quarter 2026 financial results for the quarter ended July 3, 2026, disclosing net sales of $93.5 million (up 111% year-over-year), net income of $8.1 million ($0.16 per diluted share), and adjusted EBITDA of $20.0 million, with material improvements in revenue, profitability, and gross margin.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-12
EX-99.5
This is a Q2 2026 news release disclosing Pan American Silver's second quarter financial results, including revenue of $1.1 billion, net earnings of $305 million ($0.72 basic EPS), and attributable free cash flow of $344 million. The release reports production metrics (6.5 million ounces of silver, 166 thousand ounces of gold), operational updates, and revised 2026 guidance. As a quarterly earnings announcement with comprehensive financial and operational results, this is a classic earnings_release event that would materially affect a reasonable investor's assessment of the registrant's financial performance and outlook.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
Jack in the Box issued a press release on August 12, 2026 announcing third quarter fiscal 2026 financial results, including same-store sales decline of 1.1%, diluted EPS from continuing operations of $1.08, and operating EPS of $0.96. The disclosure is a standard quarterly earnings announcement with detailed financial statements, operational metrics, and forward guidance, clearly fitting the earnings_release category under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
Santander Holdings USA disclosed Q2 2026 financial results showing net income of $585M (up 17.5% YoY) and net interest income of $1.5B (up 2.7% YoY), with key metrics including a CET1 ratio of 13.7% and deposit levels of $79.6B. The disclosure was made through a comprehensive fixed income investor presentation dated August 12, 2026, covering revenue, expenses, credit performance, and balance sheet trends.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-08-12
Item 2.02
This Item 2.02 disclosure reports Cisco's quarterly and fiscal year 2026 financial results, with a press release attached as Exhibit 99.1. The filing explicitly states "Cisco Systems, Inc. ("Cisco") reported its results of operations for its fiscal fourth quarter and fiscal year 2026 ended July 25, 2026." The press release contains comprehensive earnings data including revenue of $63.3 billion (up 12% YoY), net income of $13.3 billion (up 30% YoY), and EPS of $3.33 (up 31% YoY), along with forward guidance for Q1 and FY 2027. This is a standard earnings release disclosure material to investors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
Trimble reported Q2 2026 financial results (quarter ended July 3, 2026) with revenue of $972.0 million (up 11% YoY), a GAAP net loss of $(471.7) million driven by a $562.0 million goodwill impairment, and non-GAAP net income of $200.3 million. The company raised full-year 2026 guidance and announced a new $1.0 billion share repurchase authorization.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
Fossil Group issued a press release on August 12, 2026 announcing financial results for the fiscal quarter ended July 4, 2026, disclosing net sales of $209.7 million, gross margin expansion to 62.4%, operating results, and raising full-year 2026 financial guidance. This is a standard quarterly earnings release with detailed financial statements and forward guidance, clearly falling under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-12
EX-99.1
This is a quarterly earnings release for Suzano S.A. announcing consolidated results for 2Q26, including Adjusted EBITDA of R$4.7 billion, free cash flow of R$3.3 billion, and detailed operational and financial metrics. The document explicitly states "announces today its consolidated results for the second quarter of 2026 (2Q26)" and is titled "EARNINGS RELEASE 2Q26," making it a clear disclosure of quarterly financial results material to investors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
This is a clear earnings release disclosing Inovio's financial results for Q2 2026 (quarter ended June 30, 2026), including consolidated balance sheets, statements of operations, and detailed financial metrics (R&D expenses, G&A expenses, net loss per share). The filing explicitly states "INOVIO Reports Second Quarter 2026 Financial Results" and includes quantitative results such as net loss of $6.0 million ($0.07 per share) versus $23.5 million ($0.61 per share) in the prior year period, along with cash position and operational guidance through Q1 2027.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
The 8-K discloses Dolphin Entertainment's financial results for Q2 2026 and H1 2026 via Item 2.02 (Results of Operations and Financial Condition), with a press release attached as Exhibit 99.1. The filing reports Q2 revenue of $14.4 million (up 2.5% YoY), H1 revenue of $27.2 million (up 3.8% YoY), and a net loss of $1.6 million for Q2 2026. This is a standard quarterly earnings release, material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-12
Item 2.02
Natural Gas Services Group disclosed Q2 2026 financial results (quarter ended June 30, 2026) via an earnings call held on August 11, 2026, with detailed discussion of quarterly performance including rental revenue per horsepower, utilization rates, EBITDA, leverage ratios, and forward guidance.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-12
EX-99.1
This exhibit is a press release announcing HUYA Inc.'s unaudited financial results for the second quarter ended June 30, 2026. It discloses quarterly revenues (RMB1,739.3 million, up 11.0% YoY), operating results (narrowed operating loss to RMB7.0 million), and net income (RMB1.6 million vs. prior-year loss of RMB5.5 million), along with segment performance and balance-sheet data. The document explicitly states "HUYA Inc. Reports Second Quarter 2026 Unaudited Financial Results" and includes management commentary on business performance and strategic initiatives. This is a discrete earnings announcement, not a periodic financial report filing.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-12
Item 2.02
Bio-Techne Corporation disclosed fourth quarter and full-year fiscal 2026 financial results on August 12, 2026, reporting quarterly revenue of $321.2 million and annual revenue of $1.2 billion, with GAAP EPS of $0.35 (quarterly) and $1.16 (annual), and adjusted EPS of $0.52 (quarterly) and $1.93 (annual), along with detailed segment performance and non-GAAP reconciliations.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-12
Item 2.02
Liquidia Corp issued a press release announcing its financial results for the second quarter ended June 30, 2026, reporting net product sales of $170.4 million, net income of $74.7 million, and adjusted EBITDA of $96.3 million, along with comprehensive operational metrics.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
This is a clear earnings release disclosing Protalix's financial results for the second quarter and first half of 2026. The press release (Exhibit 99.1) reports Q2 2026 revenues of $19.8 million, year-to-date revenues of $53.6 million, and year-to-date net income of $22.1 million, along with full-year 2026 revenue guidance of $78.0–$83.0 million. The disclosure includes detailed financial highlights, operational updates on product commercialization (Elfabrio®) and clinical programs (PRX-115), and is accompanied by a conference call. This is a material event affecting investor assessment of the company's financial performance and operational progress.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
Humacyte issued a press release on August 12, 2026 disclosing financial results for its fiscal second quarter ended June 30, 2026, including commercial sales of Symvess ($0.4M Q2 2026 vs. $0.1M Q2 2025), net loss ($36.8M Q2 2026 vs. $37.7M Q2 2025), and cash position ($80.3M as of June 30, 2026). The filing explicitly states the press release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The disclosure includes detailed financial metrics and operational highlights material to investor assessment.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
Cypherpunk Technologies announced Q2 2026 financial results (quarter ended June 30, 2026) with net income of $39.4 million ($0.18 per diluted share), including detailed financial metrics, balance sheet data, and operational highlights. The earnings release was furnished as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
Item 2.02 discloses Milestone Pharmaceuticals' second quarter 2026 financial results via a press release furnished as Exhibit 99.1. The filing reports Q2 product revenues of $0.6 million, net loss of $28.6 million ($0.21 per share), cash position of $170.6 million, and operational highlights including CARDAMYST launch progress and Phase 3 trial activation for AFib-RVR. This is a standard earnings release disclosure material to investors assessing the company's financial condition and commercial progress.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
Century Therapeutics issued a press release on August 12, 2026 announcing Q2 2026 financial results for the quarter ended June 30, 2026, disclosing cash position of $197.2 million, R&D expenses of $19.6 million, G&A expenses of $5.8 million, and net loss of $34.6 million, along with material business updates on pipeline programs CNTY-813 (pre-IND meeting completed, IND submission on track for 4Q 2026) and CNTY-308 (clinical trial planned for 2026).
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
Aprea Therapeutics disclosed Q2 2026 financial results, including an operating loss of $4.0 million, net loss of $3.6 million, and cash position of $41.2 million, along with clinical progress updates on lead programs APR-1051 and ATRN-119.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-12
EX-99.1
This exhibit is a press release announcing WeRide's unaudited consolidated quarterly and first half financial results for the period ended June 30, 2026. The document discloses detailed financial metrics including total revenue (RMB231.7 million in Q2, up 82.2% YoY), gross margin (37.5%), operating expenses, net loss, EBITDA, and balance sheet information. The filing explicitly states it is issued "pursuant to Rule 13.09 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited" and constitutes "material inside information." This is a classic earnings release event disclosing quarterly and interim financial results.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
The filing discloses Capstone Energy+'s financial results for the first quarter of fiscal 2027 ended June 30, 2026, via a press release furnished as Exhibit 99.1. The disclosure includes revenue of $24.9 million, gross profit of $8.8 million (up 16% year-over-year), operating income of $1.0 million, and net income of $0.04 million, along with detailed operational highlights and management commentary. This is a standard quarterly earnings release material to investors assessing the company's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
Hyperion DeFi, Inc. issued a press release announcing its financial results for the fiscal quarter ended June 30, 2026, reporting record net income of $31.0M and adjusted EBITDA of $53.7M, along with detailed quarterly financial metrics and guidance. The company will host a conference call to discuss its financial and operating results, with an investor presentation furnished as a supplemental exhibit.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
Journey Medical issued a press release on August 12, 2026, announcing financial results for the three months ended June 30, 2026 (Q2 2026). The disclosure includes total revenues of $18.5 million (23% growth year-over-year), Emrosi® revenues of $8.1 million, gross margin of 67%, narrowed net loss of $0.3 million, and cash position of $25.6 million. This is a standard quarterly earnings release with consolidated financial statements and operational metrics, clearly falling under Item 2.02 Results of Operations and Financial Condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
This is a clear earnings release disclosing Q2 2026 financial results for Knightscope. The press release reports record revenue of $9.0 million (up 228% YoY), positive gross margin of $0.7 million (vs. prior-year gross loss), and net loss of $14.1 million. The disclosure includes detailed financial highlights, operational metrics, and forward guidance, which are material to investors assessing the company's financial performance and trajectory.
View raw filing on EDGAR →